New options in Helicobacter pylori eradication: Efficacy, resistance and synergy

Scandinavian Journal of Gastroenterology, Supplement

Volumn 33, Issue 225 SUPPL., 1998, Pages 36-40

  Williamson, R ^a   Pipkin, G A ^a   Wood, J R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Dual therapy; Eradication; Helicobacter pylori; Ranitidine bismuth citrate; Resistance; Synergy; Triple therapy

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; ANTIINFECTIVE AGENT; BISMUTH; DRUG DERIVATIVE; RANITIDINE;

CONFERENCE PAPER; DRUG EFFICACY; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; TIME; ANTIBIOTIC RESISTANCE; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; HELICOBACTER INFECTION; REVIEW;

ANTI-BACTERIAL AGENTS; BISMUTH; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; RANITIDINE;

EID: 0031610993     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Dixon JS. Helicobacter pylori eradication - unravelling the facts. Scand J Gastroenterol 1995;30 Suppl 212:48-62.
2. Harris AW, Misiewicz JJ. Eradication of Helicobacter pylori. Baillières Clin Gastroenterol 1995;9:583-613.
3. Penston JG, McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997;43:223-43.
4. Unge P, Berstad A. Pooled analysis of anti-Helicobacter pylori treatment regimens. Scand J Gastroenterol 1996;31 Suppl 220:27-40.
5. van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6-19.
6. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. New Engl J Med 1995;333:984-91.
7. McColm AA, McLaren A, Klinkert G, Francis MR, Connolly PC, Grinham CJ, et al. Ranitidine bismuth citrate: a novel antiulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture. Aliment Pharmacol Ther 1996;10:241-50.
8. Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, et al. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993;7:237-46.
9. Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of H. pylori infection: an evaluation of various therapeutic trials. Eur J Gastro Hepatol 1994;6:585-91.
10. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized double-blind trial. Am J Gastroenterol 1993;88:1860-4.
11. Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Ruhl GH. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994;89:39-42.
12. Unge P, Gad A, Eriksson K, Bergman B, Carling L, Ekström P, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Castro Hepatol 1993;5:325-31.
13. Weissfeld A, Simmons D, Rose P, Kidd S, Lukasik N, Siepman N. Susceptibility of Helicobacter pylori to clarithromycin and amoxycillin in the U.S. Gastroenterology 1997;112:A329.
14. Catalano F, Catanzaro R, Liberti A, Branciforte G, Brogna A. Comparative efficacy of omeprazole in association with amoxicillin or clarithromycin in Helicobacter pylori positive functional dyspepsia. Gut 1995;37 Suppl 2:A15.
15. Deltenre M, De Koster E, Van Gossum M, De Reuck M, Jonas C. Omeprazole based therapies for eradication of Helicobacter pylori. Gut 1995;37 Suppl 2:A59.
16. Breuer T, Sudhop T, Malaty HM, Goodman K, Graham DY, Malfertheiner P. Do physicians from different countries treat H. pylori positive ulcer disease differently; a comparison between America and Germany. Gut 1996;39 Suppl 3:A189.
17. Cayla R, Zerbib F, Talbi P, Mégraud F, Lamouliatte H. Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995;37 Suppl 2:A152.